Riskpilot← Back to searchSign inGet full access1928 Diagnostics AB
ABActiveOrg 5569630824GöteborgResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20148 employees
Revenue 2024
SEK 1,6M
-17% vs 2023
EBITDA margin
-258.0%
+61% vs 2023
Equity ratio
74.2%
Financial strength
Net profit 2024
SEK -4,9M
+58% vs 2023
| Revenue | SEK 1,6M | -17% |
| EBITDA | SEK -4,2M | +61% |
| Net profit | SEK -4,9M | +58% |
| Total assets | SEK 12,1M | +132% |
| Equity | SEK 9M | +606% |
| Employees | 8 | — |
Legal name
1928 Diagnostics AB
Org number
5569630824
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
25 februari 2014
Share capital
SEK 244 020
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av en av ledamöterna i förening med Staaf, Eva Susanne Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska utveckla, marknadsföra och sälja produkter och tjänster inom medicinteknik och bioteknik samt därmed förenlig verksamhet.
Address
Göteborg
Email
susanne.staaf@1928diagnostics.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 123 | 346 | 1 009 | 1 953 | 1 621 |
| Staff expenses | — | — | — | — | −6 070 |
| EBITDA | −14 297 | −16 385 | −16 625 | −10 631 | −4 181 |
| Depreciation & amort. | −659 | −442 | −934 | −1 120 | −801 |
| EBIT | −14 956 | −16 827 | −17 559 | −11 751 | −4 983 |
| Net financials | 65 | 66 | 57 | 21 | 34 |
| Profit before tax | −14 891 | −16 762 | −17 503 | −11 730 | −4 948 |
| Tax | −0 | −0 | −0 | −0 | — |
| Net profit | −14 891 | −16 762 | −17 503 | −11 730 | −4 948 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 45 702 | 29 924 | 13 617 | 5 243 | 12 147 |
| Equity | 43 041 | 26 279 | 8 778 | 1 278 | 9 017 |
| Long-term debt | 839 | 839 | 822 | 771 | 586 |
| Short-term debt | 1 822 | 2 806 | 4 017 | 3 194 | 2 543 |
| Total debt | 2 661 | 3 645 | 4 839 | 3 965 | 3 130 |
EBITDA margin
-258.0%
This company
15.8%
Market median
-1733% vs market
20202024
Equity ratio
74.2%
This company
38.2%
Market median
+94% vs market
20202024
Return on equity
-54.9%
This company
18.4%
Market median
-398% vs market
20202024
Net profit margin
-305.3%
This company
8.1%
Market median
-3869% vs market
20202024
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
20202024
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LM Chief Auditor | Chief Auditor | 2024 |
ES Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (2) | ||
KK Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
CF Chief Auditor | Chief Auditor | 2021 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Board of Directors | 2024 | |
| Board of Directors | 2021 | |
| Board of Directors | 2025 | |
| Former (5) | ||
| Chairman | 2021 – 2022 | |
| Board of Directors | 2021 – 2024 | |
| Board of Directors | 2021 – 2024 | |
| Board of Directors | 2021 – 2022 | |
| Chairman | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of 1928 Diagnostics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karin Kristina Magdalena Lagerstedt | Chief Executive Officer | 0 companies |
| Carl Fredrik Johan Gustav Waern | Chief Auditor | 0 companies |
| Linda Margareta Sandler | Chief Auditor | 0 companies |
| Eva Susanne Staaf | Chief Executive Officer | 0 companies |
| Sven Håkan Fried Krook | Chairman | 0 companies |
| Sven Olof Sköld | Chairman | 0 companies |
| José Manuel Bertikian | Board of Directors | 0 companies |
| Nils Martin Krantz | Board of Directors | 0 companies |
| Erik Josef Lind | Board of Directors | 0 companies |
| Gunnar Olof Kahlmeter | Board of Directors | 0 companies |
| Erik Arnold Kristiansson | Board of Directors | 0 companies |
| Michelle Catrin Elisabeth Capiod | Board of Directors | 0 companies |
| Jens Christian Mogensen | Chairman | 0 companies |
| Anne Camilla Huse Bondesson | Board of Directors | 0 companies |